Guggenheim Capital’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$783K Buy
45,790
+11,497
+34% +$197K 0.01% 974
2025
Q1
$2.19M Buy
34,293
+1,882
+6% +$120K 0.02% 618
2024
Q4
$3.94M Sell
32,411
-236
-0.7% -$28.7K 0.03% 479
2024
Q3
$4.08M Buy
32,647
+1,773
+6% +$221K 0.03% 594
2024
Q2
$4.88M Buy
30,874
+4,539
+17% +$717K 0.03% 525
2024
Q1
$3.41M Buy
26,335
+2,526
+11% +$327K 0.02% 689
2023
Q4
$2.3M Buy
23,809
+289
+1% +$27.9K 0.02% 785
2023
Q3
$2.85M Sell
23,520
-412
-2% -$49.9K 0.02% 684
2023
Q2
$2.74M Buy
23,932
+112
+0.5% +$12.8K 0.02% 729
2023
Q1
$3.28M Sell
23,820
-6,702
-22% -$924K 0.03% 665
2022
Q4
$3.96M Sell
30,522
-1,477
-5% -$191K 0.03% 611
2022
Q3
$3.54M Sell
31,999
-9,513
-23% -$1.05M 0.03% 623
2022
Q2
$3.11M Buy
41,512
+22
+0.1% +$1.65K 0.02% 727
2022
Q1
$3.24M Sell
41,490
-388
-0.9% -$30.3K 0.02% 821
2021
Q4
$3.77M Buy
41,878
+3,855
+10% +$347K 0.02% 792
2021
Q3
$3.52M Sell
38,023
-733
-2% -$67.8K 0.02% 800
2021
Q2
$3.01M Sell
38,756
-2,890
-7% -$225K 0.02% 883
2021
Q1
$3.1M Buy
41,646
+11,104
+36% +$827K 0.02% 815
2020
Q4
$5.21M Sell
30,542
-3,359
-10% -$573K 0.03% 554
2020
Q3
$4.76M Sell
33,901
-5,198
-13% -$730K 0.03% 547
2020
Q2
$6.27M Buy
39,099
+5,020
+15% +$805K 0.05% 432
2020
Q1
$3.33M Sell
34,079
-7,014
-17% -$686K 0.03% 605
2019
Q4
$5.3M Sell
41,093
-1,929
-4% -$249K 0.04% 597
2019
Q3
$3.24M Buy
43,022
+2,857
+7% +$215K 0.03% 809
2019
Q2
$6.1M Sell
40,165
-6,400
-14% -$972K 0.05% 494
2019
Q1
$5.55M Sell
46,565
-1,665
-3% -$198K 0.05% 559
2018
Q4
$5.26M Buy
48,230
+5,838
+14% +$637K 0.04% 537
2018
Q3
$6.85M Sell
42,392
-7,275
-15% -$1.18M 0.04% 528
2018
Q2
$6.56M Sell
49,667
-7,329
-13% -$969K 0.04% 541
2018
Q1
$4.22M Sell
56,996
-8,351
-13% -$619K 0.01% 1117
2017
Q4
$3.64M Sell
65,347
-18,370
-22% -$1.02M 0.01% 1224
2017
Q3
$3.8M Buy
83,717
+167
+0.2% +$7.57K 0.01% 1219
2017
Q2
$2.82M Sell
83,550
-3,923
-4% -$132K 0.01% 1372
2017
Q1
$2.59M Buy
87,473
+1,704
+2% +$50.4K 0.01% 1467
2016
Q4
$2.35M Sell
85,769
-7,641
-8% -$210K 0.01% 1550
2016
Q3
$5.74M Sell
93,410
-30,459
-25% -$1.87M 0.02% 945
2016
Q2
$2.36M Buy
+123,869
New +$2.36M 0.01% 1455
2016
Q1
Sell
-126,065
Closed -$4.86M 2990
2015
Q4
$4.86M Buy
126,065
+59,721
+90% +$2.3M 0.01% 1029
2015
Q3
$2.13M Buy
66,344
+56,400
+567% +$1.81M 0.01% 1551
2015
Q2
$303K Sell
9,944
-1,955
-16% -$59.6K ﹤0.01% 2681
2015
Q1
$158K Sell
11,899
-190,771
-94% -$2.53M ﹤0.01% 2817
2014
Q4
$2.93M Buy
202,670
+76,493
+61% +$1.11M 0.01% 1454
2014
Q3
$2.66M Buy
126,177
+30,429
+32% +$642K 0.01% 1538
2014
Q2
$2.85M Sell
95,748
-27,564
-22% -$821K 0.01% 1501
2014
Q1
$2.96M Sell
123,312
-24,132
-16% -$580K 0.01% 1446
2013
Q4
$3M Buy
147,444
+38,215
+35% +$778K 0.01% 1403
2013
Q3
$5.16M Sell
109,229
-4,611
-4% -$218K 0.02% 1067
2013
Q2
$4.33M Buy
+113,840
New +$4.33M 0.02% 1115